{
  "actions": [
    {
      "acted_at": "2019-09-26",
      "action_code": "Intro-H",
      "references": [],
      "text": "Introduced in House",
      "type": "action"
    },
    {
      "acted_at": "2019-09-26",
      "action_code": "H11100",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Referred to the House Committee on Energy and Commerce.",
      "type": "referral"
    },
    {
      "acted_at": "2019-09-27",
      "action_code": "",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "text": "Referred to the Subcommittee on Health.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "hr4538-116",
  "bill_type": "hr",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF"
    },
    {
      "activity": [
        "referral"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF",
      "subcommittee": "Subcommittee on Health",
      "subcommittee_id": "14"
    }
  ],
  "congress": "116",
  "cosponsors": [
    {
      "bioguide_id": "M001180",
      "district": "1",
      "name": "McKinley, David B.",
      "original_cosponsor": true,
      "sponsored_at": "2019-09-26",
      "state": "WV",
      "title": "Rep.",
      "withdrawn_at": null
    }
  ],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2019-09-26",
  "number": "4538",
  "official_title": "To amend title III of the Public Health Service Act to limit the orphan drug exclusion under the drug discount program under section 340B of such title.",
  "popular_title": null,
  "related_bills": [],
  "short_title": "Closing Loopholes for Orphan Drugs Act",
  "sponsor": {
    "bioguide_id": "W000800",
    "district": null,
    "name": "Welch, Peter",
    "state": "VT",
    "title": "Rep.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2019-09-26",
  "subjects": [
    "Drug therapy",
    "Health",
    "Health care costs and insurance",
    "Inflation and prices",
    "Prescription drugs"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in House",
    "asOf": "2019-09-26",
    "date": "2021-02-21T01:02:50Z",
    "text": "Closing Loopholes for Orphan Drugs Act\n\nThis bill amends the Public Health Service Act to revise the 340B Drug Pricing Program, which currently requires drug manufacturers to discount orphan drugs (i.e., drugs for rare conditions) for certain entities covered by the program. The bill discounts orphan drugs that are not being used to treat rare conditions for all entities covered by the program."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Closing Loopholes for Orphan Drugs Act",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "To amend title III of the Public Health Service Act to limit the orphan drug exclusion under the drug discount program under section 340B of such title.",
      "type": "official"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Closing Loopholes for Orphan Drugs Act",
      "type": "short"
    }
  ],
  "updated_at": "2022-11-01T13:49:48Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/116/hr/BILLSTATUS-116hr4538.xml"
}